A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...

Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 5.3% over the past three months. Since the market usually pay for a company’s long-term financial health, we ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...

Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...